SCHEMBL4547608

SCHEMBL4547608

CCCOCC(COC)OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKD3 O94806 2/20 0.48
PRKCG P05129 2/20 0.48
PRKCB P05771 2/20 0.48
PRKCA P17252 2/20 0.48
PRKCH P24723 2/20 0.48
PRKCI P41743 2/20 0.48
PRKCE Q02156 2/20 0.48
PRKCQ Q04759 2/20 0.48
PRKCZ Q05513 2/20 0.48
PRKCD Q05655 2/20 0.48
PRKD1 Q15139 2/20 0.48
LPAR1 Q92633 7/20 0.47
LPAR3 Q9UBY5 7/20 0.47
LPAR5 Q9H1C0 6/20 0.47
LPAR6 P43657 5/20 0.47
LPAR4 Q99677 5/20 0.47
LPAR2 Q9HBW0 5/20 0.47
HSD17B10 Q99714 1/20 0.46
USP2 O75604 1/20 0.42
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16406021 0.91 PRKD3 (0.46) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL14007343 0.88 PRKD3 (0.56) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL4547618 0.88 PRKD3 (0.56) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL6664986 0.86 USP2 (0.48) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL14843018 0.86 PRKD3 (0.65) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL19668158 0.86 USP2 (0.48) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL6618667 0.85 HSD17B10 (0.46) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL15780380 0.85 HSD17B10 (0.46) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL14842644 0.84 PRKD3 (0.68) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL7032675 0.84 PRKD3 (0.68) PRKD3PRKCGPRKCBPRKCAPRKCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9312127-B2 Method for producing semiconductor apparatus substrate SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-04-12 US disclosed
US-20160096977-A1 COMPOSITION FOR FORMING A COATING TYPE SILICON-CONTAINING FILM, SUBSTRATE, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-04-07 US disclosed
US-9248693-B2 Patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-02-02 US disclosed
US-8822625-B2 Method for providing higher molecular weight natural oil polyols without loss of functionality MCPU Polymer Engineering, LLC (US) 2014-09-02 US disclosed
US-8715913-B2 Silicon-containing resist underlayer film-forming composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-05-06 US disclosed
US-20130284698-A1 PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-10-31 US disclosed
EP-2599819-A1 Silicon-containing resist underlayer film-forming composition and patterning process Shin-Etsu Chemical Co., Ltd. (JP) 2013-06-05 EP disclosed
EP-2599818-A1 Silicon-containing resist underlayer film-forming composition and patterning process Shin-Etsu Chemical Co., Ltd. (JP) 2013-06-05 EP disclosed
US-20130137041-A1 SILICON-CONTAINING RESIST UNDERLAYER FILM-FORMING COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-05-30 US disclosed
US-20120116043-A1 Method for providing higher molecular weight natural oil polyols without loss of functionality MCPU Polymer Engineering LLC, a California limited liability company 2012-05-10 US disclosed
US-20120108512-A1 STABLE PHARMACEUTICAL COMPOSITIONS OF PEPTIDE DERIVATIZED USING AN OXIME LINKER NOVO NORDISK HEALTH CARE AG (CH) 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108512-A1 STABLE PHARMACEUTICAL COMPOSITIONS OF PEPTIDE DERIVATIZED USING AN OXIME LINKER PTMS, NGLY1, IAPP PRKD3 3027/4885PRKCG 3835/4885PRKCB 4358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.